Continuum Health Ventures

Continuum Health Ventures is an early-stage venture capital firm dedicated to investing in the future of Healthtech, TechBio, and Longevity. The firm focuses on backing visionary founders who leverage artificial intelligence and biology to transition medicine from a reactive 'sickcare' model to a proactive, preventative healthcare approach. Their investment thesis centers on the convergence of health and technology within the Fifth Industrial Revolution, aiming to digitize healthcare and enable precision and personalized interventions for early disease identification and healthspan extension.

Founded in 2022, Continuum Health Ventures was co-founded by Ricky Mehra and Dr. Daniel Kraft, who also serve as General Partners. The firm's mission is to seed, nurture, and accelerate the next generation of startups poised to disrupt traditional healthcare. They emphasize active, early investment and aim to be committed partners throughout a venture's journey.

The firm boasts a diverse portfolio of investments in companies pioneering advancements in healthcare technology. Notable portfolio companies include Ampa Health, Immunis, CardiaTec, and ViewsML. These investments span areas such as neurotechnology tools for brain disorder treatment, cell therapies for age-related conditions, novel therapeutic discovery platforms for cardiovascular diseases, and AI-driven virtual biomarker staining platforms.

The Continuum Health Ventures team is comprised of individuals with deep clinical expertise, scientific backgrounds, and venture capital experience. General Partners Ricky Mehra and Dr. Daniel Kraft lead a robust network of Fellows, Scientific Advisors, and Venture Partners. This collective expertise allows the firm to provide strategic capital, technical and clinical guidance, and operational support, helping founders navigate complex regulatory pathways, validate biological innovations, and scale their healthspan-focused solutions.